Cargando…
Class 1C antiarrhythmic drugs in atrial fibrillation and coronary artery disease
BACKGROUND: Class 1C antiarrhythmic drugs (AADs) are effective first‐line agents for atrial fibrillation (AF) treatment. However, these agents commonly are avoided in patients with known coronary artery disease (CAD), due to known increased risk in the postmyocardial infarction population. Whether 1...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079139/ https://www.ncbi.nlm.nih.gov/pubmed/31912933 http://dx.doi.org/10.1111/jce.14335 |